These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23237209)

  • 1. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.
    Wang CC; Mao TL; Yang WC; Jeng YM
    Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
    Conner JR; Hirsch MS; Jo VY
    Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of caveolin-1 in renal neoplasms.
    Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
    Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
    Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
    Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J; Park CK; Kim M; Joo JW; Cho NH
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of S-100 protein in renal cell neoplasms.
    Lin F; Yang W; Betten M; Teh BT; Yang XJ;
    Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Garcia E; Li M
    Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
    Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
    Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
    Zhou J; Yang X; Zhou L; Zhang P; Wang C
    Dis Markers; 2019; 2019():4708154. PubMed ID: 31737127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
    Kruck S; Hennenlotter J; Vogel U; Schilling D; Gakis G; Hevler J; Kuehs U; Stenzl A; Schwentner C
    BJU Int; 2012 Feb; 109(4):634-8. PubMed ID: 21711439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
    Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin expression in normal kidney tissue and renal carcinomas.
    Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR
    Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
    Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
    Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
    Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
    Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin expression in renal cell carcinoma and oncocytoma.
    Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F
    APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.